Abstract:LKB1 is a tumor suppressor that is constitutionally mutated in a cancer-prone condition, called Peutz-Jeghers syndrome, as well as somatically inactivated in a sizeable fraction of lung and cervical neoplasms. The LKB1 gene encodes a serine/threonine kinase that associates with the pseudokinase STRAD (STE-20-related pseudokinase) and the scaffolding protein MO25, the formation of this heterotrimeric complex promotes allosteric activation of LKB1. We have previously reported that the molecular chaperone heat shock protein 90 (Hsp90) binds to and stabilizes LKB1. Combining pharmacological studies and RNA interference approaches, we now provide evidence that the co-chaperone Cdc37 participates to the regulation of LKB1 stability. It is known that the Hsp90-Cdc37 complex recognizes a surface within the N-terminal catalytic lobe of client protein kinases. In agreement with this finding, we found that the chaperones Hsp90 and Cdc37 interact with an LKB1 isoform that differs in the C-terminal region, but not with a novel LKB1 variant that lacks a portion of the kinase N-terminal lobe domain. Reconstitution of the two complexes LKB1-STRAD and LKB1-Hsp90-Cdc37 with recombinant proteins revealed that the former is catalytically active whereas the latter is inactive. Furthermore, consistent with a documented repressor function of Hsp90, LKB1 kinase activity was transiently stimulated upon dissociation of Hsp90. Finally, disruption of the LKB1-Hsp90 complex favors the recruitment of both Hsp/Hsc70 and the U-box dependent E3 ubiquitin ligase CHIP (carboxyl terminus of Hsc70-interacting protein) that triggers LKB1 degradation. Taken together, our results establish that the Hsp90-Cdc37 complex controls both the stability and activity of the LKB1 kinase. This study further shows that two chaperone complexes with antagonizing activities, Hsp90-Cdc37 and Hsp/Hsc70-CHIP, finely control the cellular level of LKB1 protein.

Structural Insights into Regulatory Mechanisms of Mo25-Mediated Kinase Activation

Structure of the MST4 in complex with MO25 provides insights into its activation mechanism.

Structural Insights into the Enzymatic Mechanism of the Pathogenic MAPK Phosphothreonine Lyase.

Structural and Biochemical Insights into the Activation Mechanisms of Germinal Center Kinase OSR1*

A novel non-canonical mechanism of regulation of MST3 (mammalian Sterile20-related kinase 3)

MEKK2 and MEKK3 Orchestrate Multiple Signals to Regulate Hippo Pathway.

Structural and mechanistic insights into Mps1 kinase activation.

Integrative Structural Modeling of a Multidomain Polo-Like Kinase

Structural Basis for the Regulation of Maternal Embryonic Leucine Zipper Kinase.

Dynamic and structural insights into allosteric regulation on MKP5 a dual-specificity phosphatase

Structural basis of docking interactions between ERK2 and MAP kinase phosphatase 3.

Molecular Insights on the Conformational Transitions and Activity Regulation of the c-Met Kinase Induced by Ligand Binding

Structural and dynamic insights into the mechanism of allosteric signal transmission in ERK2-mediated MKP3 activation.

Molecular chaperone complexes with antagonizing activities regulate stability and activity of the tumor suppressor LKB1

Theoretical Investigation of the Structural Characteristics in the Active State of Akt1 Kinase

Multiplexed Quantitative MALDI MS Approach for Assessing Activity and Inhibition of Protein Kinases Based on Postenrichment Dephosphorylation of Phosphopeptides by Metal-Organic Framework-Templated Porous CeO2.

Crystal Structure of the Phosphorylated Arabidopsis MKK5 Reveals Activation Mechanism of MAPK Kinases

Anatomy of a structural pathway for activation of the catalytic domain of Src kinase Hck

Architecture and Activation of Human Muscle Phosphorylase Kinase

Midkine noncanonically suppresses AMPK activation through disrupting the LKB1-STRAD-Mo25 complex

Understanding the P-Loop Conformation in the Determination of Inhibitor Selectivity Toward the Hepatocellular Carcinoma-Associated Dark Kinase STK17B